![Vinay Bhaskar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vinay Bhaskar
Geen lopende functies
Profiel
Vinay Bhaskar served as a Director at Amphivena Therapeutics, Inc. and Tizona Therapeutics, Inc. He was also the Principal at MPM BioImpact, Inc from 2016 to 2021.
Bhaskar served as the Chief Operating Officer at Werewolf Therapeutics, Inc. and Turmeric Acquisition Corp.
Bhaskar holds a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California, Davis.
Eerdere bekende functies van Vinay Bhaskar
| Bedrijven | Functie | Einde |
|---|---|---|
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Directeur/Bestuurslid | 01-09-2021 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01-07-2021 |
| TURMERIC ACQUISITION CORP. | Operationeel Directeur | 30-04-2021 |
| WEREWOLF THERAPEUTICS, INC. | Operationeel Directeur | - |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Directeur/Bestuurslid | - |
Opleiding van Vinay Bhaskar
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
26
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
